Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection

被引：63
|
作者：
Campbell, S [1 ]
Ghosh, S [1 ]
机构：
[1] Western Gen Hosp, Gastrointestinal Unit, Dept Med Sci, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2001年 / 13卷 / 02期
关键词：
Crohn's disease; hepatitis C; infliximab; tumour necrosis factor alpha;
D O I：
10.1097/00042737-200102000-00016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Treatment of Crohn's disease with infliximab is an important drug therapy for patients with refractory and fistulating disease. There are concerns over its use in a proportion of Crohn's patients with concurrent hepatitis C infection, since there are theoretical risks of accelerated hepatic decompensation due to the immunomodulatory impact of infliximab. We report a patient with both Crohn's disease and ongoing active hepatitis C infection who underwent infliximab therapy, with no worsening of his liver function or PCR status. Eur J Gastroenterol Hepatol 13:191-192 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码：191 / 192
页数：2
相关论文
共 50 条
  • [1] Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection
    Garcia-Sánchez, MD
    Gómez-Camacho, F
    Poyato-González, A
    Iglesias-Flores, EM
    de Dios-Vega, JF
    Sancho-Zapatero, R
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (05) : 701 - 702
  • [2] Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B
    Ueno, Y
    Tanaka, S
    Shimamoto, M
    Miyanaka, Y
    Hiyama, T
    Ito, M
    Kitadai, Y
    Yoshihara, M
    Sumii, M
    Chayama, K
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (01) : 163 - 166
  • [3] Infliximab Therapy for Crohn’s Disease in a Patient with Chronic Hepatitis B
    Yoshitaka Ueno
    Shinji Tanaka
    Masaru Shimamoto
    Yoshihiro Miyanaka
    Toru Hiyama
    Masanori Ito
    Yasuhiko Kitadai
    Masaharu Yoshihara
    Masaharu Sumii
    Kazuaki Chayama
    Digestive Diseases and Sciences, 2005, 50 : 163 - 166
  • [4] Use of infliximab, pegylated interferon and ribavirin in a patient with Crohn's disease and hepatitis C infection
    Maddala, Y
    Cotoman, G
    Lebovitz, P
    Aggrawal, R
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S262 - S263
  • [5] Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease
    Abdelmalek, Manal F.
    Liu, Chen
    Valentine, John F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (06): : 1333 - 1334
  • [6] Plasmablastic lymphoma associated to Crohn's disease and hepatitis C virus chronic infection
    Plaza, Rocio
    Ponferrada, Angel
    Benito, Dulce M.
    Arevalo, Noelia
    Angeles Foncillas, Maria
    Luisa de Fuenmayor, Maria
    Aldeguer, Mercedes
    JOURNAL OF CROHNS & COLITIS, 2011, 5 (06): : 628 - 632
  • [7] Autoimmune hepatitis during infliximab therapy for Crohn's disease: A case report
    Doyle, Adam
    Forbes, Geoff
    Kontorinis, Nick
    JOURNAL OF CROHNS & COLITIS, 2011, 5 (03): : 253 - 255
  • [8] Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients:: need for primary prophylaxis
    Esteve, M
    Saro, C
    González-Huix, F
    Suarez, F
    Forné, M
    Viver, JM
    GUT, 2004, 53 (09) : 1363 - 1365
  • [9] Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C
    Scherzer, T. -M.
    Staufer, K.
    Novacek, G.
    Steindl-Munda, P.
    Schumacher, S.
    Hofer, H.
    Ferenci, P.
    Vogelsang, H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (06) : 742 - 748
  • [10] Infliximab therapy for pediatric Crohn's disease
    Veres, Gabor
    Baldassano, Robert N.
    Mamula, Petar
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (12) : 1869 - 1880
12345